Pineapple Financial's decision to migrate its
$10B mortgage portfolio on-chain via Injective has garnered remarkable attention. Forecasts for
INJ price yield mixed results, especially as meanwhile chains like
Starknet, Base, Ink, Solana stand out for their capital inflows. Among the possible future developments for Injective, the launch of ETF offers much potential. The recent price surge seems to correlate with
upgrade approval and $2M accumulation. An $8.9M order followed after
Pineapple launched a $100M treasury. INJ's blockchain technology allowed the introduction of
tokenized gold into 24/7 markets. Notable progression was also made when
Korea University Blockchain Institute joined as a validator in the ecosystem. Looking to expand its benefits, Injective recently launched a native EVM to provide
faster, cheaper DeFi. Staking ETF filing presents more possibilities for altcoin fund demand and
SEC public comment phase enters Injective ETF proposal, adding another dimension of potential growth. Despite
INJ token dipping 8%, Injective's total value locked (TVL) climbed 14%. Seeing the future of finance in INJ, investors also took note of
Binance suspending INJ deposits and withdrawals for upgrading the network. Injective made waves with the launch of
SBET as the first on-chain digital treasury. Injective backed several projects aiding towards the overall firm value.
Agora's AUSD was the
first native stablecoin launched by Injective.
Underperforming in crypto markets, Injective now plans to establish a layer-3 chain on Arbitrum.
Promising price predictions for INJ also suggest a bright outlook in cryptocurrency. An INJ year-to-date gain of
3,000% was noted along with
Massive INJ token burn that further increased demand. Speculation surges over Injective's forthcoming ventures with discussions around
interoperability and innovation.
Injective Coin News Analytics from Sat, 05 Dec 2020 08:00:00 GMT to Thu, 05 Mar 2026 05:20:12 GMT -
Rating 7
- Innovation 8
- Information 8
- Rumor 6
